BioCentury
ARTICLE | Clinical News

Androderm testosterone regulatory update

October 31, 2011 7:00 AM UTC

FDA approved 2 and 4 mg doses of transdermal Androderm testosterone for daily use as testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous test...